Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Abliva AB (publ) (ST: ABLI)

 
ABLI Technical Analysis
5
As on 22nd Nov 2024 ABLI STOCK Price closed @ 0.13 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.22 & Strong Sell for SHORT-TERM with Stoploss of 0.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABLISTOCK Price

Open 0.14 Change Price %
High 0.14 1 Day -0.01 -7.14
Low 0.13 1 Week -0.01 -7.14
Close 0.13 1 Month -0.02 -13.33
Volume 974099 1 Year -0.09 -40.91
52 Week High 0.28 | 52 Week Low 0.12
 
ST Sweden Most Active Stocks
TANGI 0.00 %
FING-B 0.08 0.00%
SBB-B 4.00 1.78%
LUNE 21.97 6.65%
SNM 0.88 2.33%
DIABIO 0.03 0.00%
WYLD 0.02 0.00%
NIBE-B 45.75 1.87%
HDW-B 0.00 %
EURA 0.01 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
STAR-A 0.26 30.00%
LCLEAN 3.20 25.49%
QIIWI 3.10 22.05%
APTR 0.23 21.05%
FLUI 0.06 20.00%
CLS-B 4.50 19.05%
SIVE 2.24 16.06%
SIVE 2.24 16.06%
 
ST Sweden Top Losers Stocks
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
LOHILO 1.58 -18.56%
ADDV-A 9.82 -18.17%
PHARM 0.56 -16.42%
PHARM 0.56 -16.42%
ONCOZ 3.50 -13.37%
SCOL 0.07 -12.50%
 
 
ABLI
Daily Charts		 ABLI
Intraday Charts		 Whats New @
Bazaartrend		 ABLI
Free Analysis
 
ABLI Important Levels Intraday
RESISTANCE0.15
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
SUPPORT0.12
SUPPORT0.12
SUPPORT0.12
SUPPORT0.11
 
ABLI Forecast November 2024
Share
4th UP Forecast0.28
3rd UP Forecast0.23
2nd UP Forecast0.2
1st UP Forecast0.17
1st DOWN Forecast0.09
2nd DOWN Forecast0.06
3rd DOWN Forecast0.03
4th DOWN Forecast-0.02
 
ABLI Weekly Forecast
4th UP Forecast0.19
3rd UP Forecast0.17
2nd UP Forecast0.16
1st UP Forecast0.15
1st DOWN Forecast0.11
2nd DOWN Forecast0.10
3rd DOWN Forecast0.09
4th DOWN Forecast0.07
 
ABLI Forecast2024
4th UP Forecast0.57
3rd UP Forecast0.43
2nd UP Forecast0.34
1st UP Forecast0.26
1st DOWN Forecast0
2nd DOWN Forecast-0.08
3rd DOWN Forecast-0.17
4th DOWN Forecast-0.31
 
 
ABLI Other Details
Segment EQ
Market Capital 213392208.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABLI Address
ABLI
 
ABLI Latest News
 
Your Comments and Response on Abliva AB (publ)
 
ABLI Business Profile
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service